DSIP
Also known as: Delta Sleep-Inducing Peptide
Delta Sleep-Inducing Peptide | Sleep & Stress Modulator
Overview
DSIP is a naturally occurring nonapeptide discovered in 1974 in rabbit brain. Originally isolated for sleep-promoting properties, it has diverse neuromodulatory effects including stress reduction, pain modulation, and endocrine regulation without traditional sedative effects.
Key benefits
- Enhanced sleep quality through slow-wave sleep promotion
- Stress reduction via cortisol modulation
- Potential pain relief
- Mood stabilization without traditional sedative effects
- No tolerance or dependence reported
- Short cycle duration (5-10 days)
Mechanism of action
Modulates multiple neurotransmitter systems including GABA enhancement, NMDA receptor interaction, and endogenous opioid system modulation. Also regulates hypothalamic-pituitary-adrenal axis for stress response.
Molecular data
- Type
- Nonapeptide
- Half-life
- ~15 minutes (in vitro)
Sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Indications
What the research community uses this compound for, with self-reported effectiveness.
Sleep
Deep Sleep Enhancement
Most effectivePromotes delta wave sleep, the most restorative sleep phase for physical recovery.
Sleep Efficiency
Most effectiveReduces sleep latency and nocturnal awakenings without morning grogginess.
Natural Sleep Architecture
EffectiveSupports natural sleep cycles rather than forcing sedation like traditional sleep aids.
Mood
Stress Response Modulation
EffectiveHelps regulate cortisol and stress response through HPA axis modulation.
Mood Stabilization
EffectiveSupports emotional balance without sedation.
Anxiety Reduction
EffectiveMay help reduce anxiety through neuromodulatory effects.
Pain & Recovery
Pain Modulation
ModerateSignificantly reduced pain levels in 6 of 7 patients with chronic pain conditions.
Withdrawal Support
ModerateHelps manage withdrawal symptoms in alcohol and opioid-dependent patients.
Athletic Recovery
ModerateSupports post-training recovery through enhanced sleep quality.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Subcutaneous injection is the standard route. Best taken 30-60 minutes before bedtime. Some prefer earlier evening dosing for gradual onset.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Sleep enhancement | 100-200mcg | Once nightly | SubQ |
| Chronic pain support | 250-300mcg | Daily | SubQ or IV |
| Stress management | 150mcg | Evening | SubQ |
| Withdrawal support | 200-300mcg | Twice daily | IV preferred |
| Athletic recovery | 100-150mcg | Post-training | SubQ |
Preparation
You will need
- DSIP peptide vial (1-5mg typical)
- Bacteriostatic water (1-2mL)
- Insulin syringes (0.3-0.5mL)
- Alcohol swabs
- Sterile needle for mixing
Steps
- Clean vial tops with alcohol swab and let dry completely
- For 1mg vial, add 1mL bacteriostatic water (creates 1000mcg/mL)
- Inject water slowly down vial side to prevent foaming
- Gently roll between palms - do not shake
- Solution should be clear and colorless
- For 100mcg dose, draw 0.1mL (10 units on insulin syringe)
- Store reconstituted peptide in refrigerator immediately
Work out the water volume and syringe units in the reconstitution calculator →
Nasal
Intranasal spray offers convenient administration with limited stability data.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Sleep induction | 200-300mcg | Once at bedtime | Nasal spray |
| Stress relief | 150-200mcg | Twice daily | Nasal spray |
| Neuroprotection | 300-400mcg | Daily | Nasal spray |
Preparation
Steps
- Reconstitute DSIP to 2mg/mL concentration
- Transfer to sterile nasal spray bottle
- Prime pump to ensure consistent delivery
- Each spray should deliver ~100mcg (0.05mL)
- Test spray volume before use
- Label with concentration and date
- Use within 10 days
Work out the water volume and syringe units in the reconstitution calculator →
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
GABA Agonists
MonitorDSIP enhances GABA - watch for excessive sedation.
Opioid Medications
MonitorMay modulate opioid receptors; requires professional supervision.
Melatonin
SynergisticBoth regulate sleep-wake cycles; complementary benefits.
Cortisol Modulators
CompatibleCan combine for comprehensive stress management.
Selank
SynergisticComplementary anxiolytic effects.
Semax
CompatibleDifferent mechanisms; can optimize 24-hour function.
Growth Hormone Peptides
CompatibleNo direct interaction; DSIP may support natural GH release during sleep.
Epitalon
SynergisticBoth support circadian regulation and sleep quality.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- First Dose
Noticeable sleep pressure and easier sleep onset
- Night 1-3
Deeper sleep, fewer awakenings, vivid dreams possible
- Day 2-5
Improved morning refreshment, stable daytime energy
- Day 5-10
Cumulative stress reduction, mood improvements
- Post-Cycle
Benefits may persist 1-2 weeks after stopping
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Generally well-tolerated with minimal side effects
- Mild drowsiness or dizziness initially (some users)
- Occasional headaches in sensitive individuals
- No tolerance or dependence reported in studies
Stop signs — stop and seek advice
- Excessive daytime sedation
- Paradoxical insomnia or agitation
- Persistent headaches
- Any allergic reactions
- Mood changes or depression
- Unusual dreams causing distress
Contraindications
- Avoid driving until effects are known
- Pregnancy or breastfeeding
Monitoring
- Monitor initial dose tolerance
- Track sleep quality improvements
- Watch for mood stability changes
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- White lyophilized powder before reconstitution
- Clear and colorless solution when properly mixed
- Reputable source with third-party testing
Warning signs
- Short stability period - use within 14 days when reconstituted
- Protect from light exposure and temperature fluctuations
- Limited nasal formulation stability (use within 10 days)
Stop signs — don't use
- Yellow or cloudy solution indicates degradation or contamination
- Discolored powder
Recent research
Newer papers and trial readouts on file for this compound, with source and date.
2006 · Journal of Neurochemistry
Delta Sleep-Inducing Peptide (DSIP): A Still Unresolved Riddle
Comprehensive review of DSIP research from discovery to current understanding; notes the peptide's diverse neuromodulatory effects beyond sleep, including stress protection, pain modulation, and endocrine regulation.
2021 · Pharmaceutics
Delta Sleep-Inducing Peptide Recovers Motor Function After Focal Stroke in Rats
Intranasal DSIP (120 mcg/kg) for 8 days accelerated motor recovery after focal stroke in rats, suggesting neuroprotective applications beyond sleep modulation.
1987 · European Neurology
Effects of Delta-Sleep-Inducing Peptide on 24-Hour Sleep-Wake Behaviour in Severe Chronic Insomnia
7 severe chronic insomniacs treated with 10 DSIP injections; sleep normalized in all but 1 case, with benefits persisting for follow-up periods of 3-7 months.
References
Primary literature and clinical-trial data informing this entry.
Effects of Delta Sleep-Inducing Peptide on Sleep of Chronic Insomniac Patients: A Double-Blind Study
Schneider-Helmert D · Neuropsychobiology · 1992
Double-blind placebo-controlled study; DSIP (15-30 nmol for 6 consecutive nights) showed higher sleep efficiency and shorter sleep latency, though statistical effects were weak.
Therapeutic Effects of Delta-Sleep-Inducing Peptide (DSIP) in Patients with Chronic, Pronounced Pain Episodes: A Clinical Pilot Study
Schoenenberger GA, Schneider-Helmert D · European Neurology · 1984
7 patients with chronic pain (migraine, vasomotor headaches); 25 nmol IV DSIP for 10 days significantly reduced pain levels in 6 of 7 patients.
DSIP in the Treatment of Withdrawal Syndromes from Alcohol and Opiates
Dick P, Costa C, Fayolle K, et al. · European Neurology · 1984
107 patients (47 alcohol, 60 opiate withdrawal); DSIP (25 nmol/kg IV) produced beneficial effects in 97% of opiate addicts and 87% of alcoholics with immediate onset and lasting symptom relief.
Acute and Delayed Effects of DSIP (Delta Sleep-Inducing Peptide) on Human Sleep Behavior
Schneider-Helmert D, Schoenenberger GA · International Journal of Peptide and Protein Research · 1983
6 normal volunteers; 25 nmol/kg IV DSIP induced 59% increase in total sleep time within 130 minutes; improved subsequent night sleep efficiency without sedation.
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats After Focal Stroke
Tukhovskaya EA, Ismailova AM, Shaykhutdinova ER, et al. · Pharmaceutics · 2021
120 mcg/kg intranasal DSIP for 8 days accelerated motor function recovery (rotarod test) after focal stroke in rats; brain infarction was smaller but not statistically significant.
Successful Treatment of Withdrawal Symptoms with Delta Sleep-Inducing Peptide
Larbig W, Gerber WD, Kluck M, Schoenenberger GA · Neuropsychobiology · 1984
DSIP (25 nmol/kg IV) administered to 67 patients; beneficial effect in 48 of 49 evaluable patients (22 alcoholics and 26 of 27 opiate addicts) with good tolerance.
Last updated . How this page was sourced is described in the methodology.